| Oct 28 |
DaVita Q3 2024 Earnings Preview
|
| Oct 28 |
DaVita Emphasizes Commitment to Whole-Person Care with Investment in National Kidney Foundation PEERS Program
|
| Oct 25 |
DVA Q3 Estimates Unchanged Before Earnings: How to Play the Stock?
|
| Oct 23 |
DaVita HealthCare (DVA) Stock Moves -0.23%: What You Should Know
|
| Oct 23 |
DaVita Research Centers on Upstream CKD Management; Access & Equity during ASN's Kidney Week 2024
|
| Oct 22 |
DaVita HealthCare (DVA) Increases Despite Market Slip: Here's What You Need to Know
|
| Oct 22 |
DaVita celebrates kidney care community achievements in year one of largest-ever value-based care program
|
| Oct 21 |
AVTR Stock Flat Following the Close of Divestiture Deal With Audax
|
| Oct 17 |
DaVita Appoints Jessica Hergenreter as Chief People Officer
|
| Oct 17 |
GKOS Stock Rises on Positive Phase 3 Confirmatory Trial for Epioxa
|
